Aurora Daljit Singh Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
1
Insider Sells Sum
$14,347.23

Insider Activity of Aurora Daljit Singh

According to the SEC Form 4 filings, Aurora Daljit Singh, being in a position of

  1. See Remarks at Neumora Therapeutics, Inc. Common Stock,
    оver the last 12 months, has bought 0 shares, and sold 574701 share for $1.03M,
    over all time since 2025-02-18, has bought 0 shares, and sold 583266 shares for $1.04M.

Biography of Aurora Daljit Singh

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $1,030,5837100

Comparison of Insiders on Amount of Buys and Sells

2026-08-21SaleNeumora Therapeutics, Inc. Common Stock
NMRA
See Remarks
41,608
0.022%
$1.60$66,380-58.43%
2026-08-20SaleNeumora Therapeutics, Inc. Common Stock
NMRA
See Remarks
134,452
0.0725%
$1.51$203,587-55.42%
2026-08-19SaleNeumora Therapeutics, Inc. Common Stock
NMRA
See Remarks
61,918
0.0335%
$1.65$101,917-58.68%
2026-08-18SaleNeumora Therapeutics, Inc. Common Stock
NMRA
See Remarks
69,149
0.0361%
$1.59$109,622-58.25%
2026-08-17SaleNeumora Therapeutics, Inc. Common Stock
NMRA
See Remarks
146,706
0.0782%
$1.50$220,135-54.49%
2026-02-17SaleNeumora Therapeutics, Inc. Common Stock
NMRA
See Remarks
6,165
0.0037%
$3.56$21,917-53.39%
2025-11-11SaleNeumora Therapeutics, Inc. Common Stock
NMRA
See Remarks
114,703
0.0741%
$2.68$307,026-34.18%
2025-02-18SaleNeumora Therapeutics, Inc. Common Stock
NMRA
Chief Strategy Officer
8,565
0.0051%
$1.68$14,347-4.05%
Total: 8
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.